Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
[Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19].
2
Zitationen
7
Autoren
2020
Jahr
Abstract
Coronavirus disease 2019 (COVID-19) is a grade B infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In pace with the spreading of the disease, biosafety risk of the biological specimen preservation in biobanks has been significantly increased and biosafety protection during biological specimen preservation become increasingly important. According to the related national rules and the corresponding guidelines of Chinese Medical Association, this paper introduced the etiology about SARS-CoV-2, epidemiology about COVID-19, and the biosafety protection principles of individuals and biological specimen storage places in the process of personal protection, protection of collection, transport, handling, preservation, detection, post-detection disposal and emergencies of biological specimen. Emphasized to carry out a strict biosafety-risk assessment on biological specimen basing on virus load information, infectivity, and sample type (possible contact transmission, aerosol transmission, and fecal oral transmission).
Ähnliche Arbeiten
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.215 Zit.
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
2014 · 5.073 Zit.
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 · 4.267 Zit.
Global estimates of visual impairment: 2010
2011 · 3.756 Zit.
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 · 3.472 Zit.